461 related articles for article (PubMed ID: 23814021)
21. Emerging Concepts in Hematopoietic Stem Cell Transplantation-Associated Renal Thrombotic Microangiopathy and Prospects for New Treatments.
Wanchoo R; Bayer RL; Bassil C; Jhaveri KD
Am J Kidney Dis; 2018 Dec; 72(6):857-865. PubMed ID: 30146419
[TBL] [Abstract][Full Text] [Related]
22. Complement blockade for TA-TMA: lessons learned from a large pediatric cohort treated with eculizumab.
Jodele S; Dandoy CE; Lane A; Laskin BL; Teusink-Cross A; Myers KC; Wallace G; Nelson A; Bleesing J; Chima RS; Hirsch R; Ryan TD; Benoit S; Mizuno K; Warren M; Davies SM
Blood; 2020 Mar; 135(13):1049-1057. PubMed ID: 31932840
[TBL] [Abstract][Full Text] [Related]
23. A Heterozygous CFHR3-CFHR1 Gene Deletion in a Pediatric Patient With Transplant-associated Thrombotic Microangiopathy Who was Treated With Eculizumab.
Nozawa A; Ozeki M; Hori T; Kawamoto N; Hirayama M; Azuma E; Fukao T
J Pediatr Hematol Oncol; 2018 Nov; 40(8):e544-e546. PubMed ID: 28991129
[TBL] [Abstract][Full Text] [Related]
24. New approaches in the diagnosis, pathophysiology, and treatment of pediatric hematopoietic stem cell transplantation-associated thrombotic microangiopathy.
Jodele S; Dandoy CE; Myers KC; El-Bietar J; Nelson A; Wallace G; Laskin BL
Transfus Apher Sci; 2016 Apr; 54(2):181-90. PubMed ID: 27156964
[TBL] [Abstract][Full Text] [Related]
25. Transplant-Associated Thrombotic Microangiopathy in the Context of Allogenic Hematopoietic Stem Cell Transplantation: Where We Stand.
Lazana I
Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674666
[TBL] [Abstract][Full Text] [Related]
26. Thrombotic microangiopathies: from animal models to human disease and cure.
Caprioli J; Remuzzi G; Noris M
Contrib Nephrol; 2011; 169():337-350. PubMed ID: 21252531
[TBL] [Abstract][Full Text] [Related]
27. Patients with hypertension-associated thrombotic microangiopathy may present with complement abnormalities.
Timmermans SAMEG; Abdul-Hamid MA; Vanderlocht J; Damoiseaux JGMC; Reutelingsperger CP; van Paassen P;
Kidney Int; 2017 Jun; 91(6):1420-1425. PubMed ID: 28187980
[TBL] [Abstract][Full Text] [Related]
28. Elevated Systemic Pentraxin-3 Is Associated With Complement Consumption in the Acute Phase of Thrombotic Microangiopathies.
Trojnar E; Józsi M; Szabó Z; Réti M; Farkas P; Kelen K; Reusz GS; Szabó AJ; Garam N; Mikes B; Sinkovits G; Mező B; Csuka D; Prohászka Z
Front Immunol; 2019; 10():240. PubMed ID: 30858847
[TBL] [Abstract][Full Text] [Related]
29. The genetic fingerprint of susceptibility for transplant-associated thrombotic microangiopathy.
Jodele S; Zhang K; Zou F; Laskin B; Dandoy CE; Myers KC; Lane A; Meller J; Medvedovic M; Chen J; Davies SM
Blood; 2016 Feb; 127(8):989-96. PubMed ID: 26603840
[TBL] [Abstract][Full Text] [Related]
30. Hypertension-associated thrombotic microangiopathy in an adult patient with complement factor H autoantibodies and a rare heterozygous variant in the
Roldão M; Valério Alves R; Escoli R; Gonçalves H; Lopes K
Clin Nephrol; 2021 Aug; 96(2):124-128. PubMed ID: 34032207
[TBL] [Abstract][Full Text] [Related]
31. [Diagnosis and treatment of microangiopathic hemolytic anemia].
Morishita E
Rinsho Ketsueki; 2015 Jul; 56(7):795-806. PubMed ID: 26251142
[TBL] [Abstract][Full Text] [Related]
32. Transplantation-Associated Thrombotic Microangiopathy Risk Stratification: Is There a Window of Opportunity to Improve Outcomes?
Jodele S; Dandoy CE; Sabulski A; Koo J; Lane A; Myers KC; Wallace G; Chima RS; Teusink-Cross A; Hirsch R; Ryan TD; Benoit S; Davies SM
Transplant Cell Ther; 2022 Jul; 28(7):392.e1-392.e9. PubMed ID: 35490975
[TBL] [Abstract][Full Text] [Related]
33. [The genetic basis of post-bone marrow transplant thrombotic microangiopathy: is this the last piece of the puzzle?].
Mancianti N; Guarnieri A; Tripodi S; Salvo DP; Rollo F; Lenoci M; Toraldo F; Bucalossi A; Garosi G
G Ital Nefrol; 2022 Feb; 39(1):. PubMed ID: 35191626
[TBL] [Abstract][Full Text] [Related]
34. Complement in Thrombotic Microangiopathies: Unraveling Ariadne's Thread Into the Labyrinth of Complement Therapeutics.
Gavriilaki E; Anagnostopoulos A; Mastellos DC
Front Immunol; 2019; 10():337. PubMed ID: 30891033
[TBL] [Abstract][Full Text] [Related]
35. Diagnostic and risk criteria for HSCT-associated thrombotic microangiopathy: a study in children and young adults.
Jodele S; Davies SM; Lane A; Khoury J; Dandoy C; Goebel J; Myers K; Grimley M; Bleesing J; El-Bietar J; Wallace G; Chima RS; Paff Z; Laskin BL
Blood; 2014 Jul; 124(4):645-53. PubMed ID: 24876561
[TBL] [Abstract][Full Text] [Related]
36. Systematic Review of Signs and Symptoms Associated with Hematopoietic Stem Cell Transplantation-Associated Thrombotic Microangiopathy.
Dandoy CE; Tsong WH; Sarikonda K; McGarvey N; Perales MA
Transplant Cell Ther; 2023 Apr; 29(4):282.e1-282.e9. PubMed ID: 36592719
[TBL] [Abstract][Full Text] [Related]
37. Thrombotic microangiopathy: new insights.
Benz K; Amann K
Curr Opin Nephrol Hypertens; 2010 May; 19(3):242-7. PubMed ID: 20186056
[TBL] [Abstract][Full Text] [Related]
38. Hematopoietic stem cell transplantation-associated thrombotic microangiopathy and the role of advanced practice providers and pharmacists.
Mahmoudjafari Z; Alencar MC; Alexander MD; Johnson DJ; Yeh J; Evans MD
Bone Marrow Transplant; 2023 Jun; 58(6):625-634. PubMed ID: 37059738
[TBL] [Abstract][Full Text] [Related]
39. The Role of Complement in HSCT-TMA: Basic Science to Clinical Practice.
Meri S; Bunjes D; Cofiell R; Jodele S
Adv Ther; 2022 Sep; 39(9):3896-3915. PubMed ID: 35781192
[TBL] [Abstract][Full Text] [Related]
40. [Advances in Diagnosis and Treatment of Transplant-Associated Thrombotic Microangiopathy --Review].
Geng YK; Wang T; Song ZQ; Yang JM
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Apr; 31(2):602-606. PubMed ID: 37096542
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
